Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial
- 31 March 2006
- journal article
- Published by Elsevier BV in Heart Rhythm
- Vol. 3 (3), 313-316
- https://doi.org/10.1016/j.hrthm.2005.11.024
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Prognostic Value of the QRS Duration in Patients With Heart Failure: A Subgroup Analysis From 24 Centers of Val-HeFTJournal of Cardiac Failure, 2005
- Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial InfarctionCirculation, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureThe New England Journal of Medicine, 2004
- QRS Duration and Shortening to Predict Clinical Response to Cardiac Resynchronization Therapy in Patients with End‐Stage Heart FailurePacing and Clinical Electrophysiology, 2004
- Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delayJournal of the American College of Cardiology, 2003
- QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failureHeart, 2003
- QRS interval time-related changes and prognosis in heart failure.The American Journal of Cardiology, 2003
- Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS durationInternational Journal of Cardiology, 2002
- Congestive Heart Failure and QRS DurationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- The prognostic significance of intermediate QRS prolongation in acute myocardial infarctionInternational Journal of Cardiology, 2001